We are live on ! Find out more
AC

Aldebaran Capital Portfolio holdings

AUM $131M
1-Year Est. Return 34.7%
This Fund
S&P 500
This Quarter Est. Return
+1.38%
1 Year Est. Return
+34.7%
3 Year Est. Return
+72.53%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$107M
AUM Growth
+$2.37M
Cap. Flow
+$1.25M
Cap. Flow %
1.16%
Top 10 Hldgs %
76.81%
Holding
36
New
3
Increased
4
Reduced
21
Closed
–

Top Buys

Rank Stock Value
1
ACRS icon
Aclaris Therapeutics
ACRS
+$1.01M
2
PMVP icon
PMV Pharmaceuticals
PMVP
+$633K
3
AMLX icon
Amylyx Pharmaceuticals
AMLX
+$523K
4
CATO icon
Cato Corp
CATO
+$91.3K
5
MSFT icon
Microsoft
MSFT
+$90.4K

Top Sells

Rank Stock Value
1
BG icon
Bunge Global
BG
+$244K
2
IWS icon
iShares Russell Mid-Cap Value ETF
IWS
+$143K
3
BRK.B icon
Berkshire Hathaway Class B
BRK.B
+$132K
4
CVX icon
Chevron
CVX
+$122K
5
SU icon
Suncor Energy
SU
+$102K

Sector Composition

Rank Sector Weight
1 Financials 25.83%
2 Energy 20.67%
3 Technology 11.64%
4 Consumer Staples 10.29%
5 Healthcare 9.72%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PMVP icon
26
PMV Pharmaceuticals
PMVP
$60.3M
$569K 0.53%
+351,243
New +$633K
AMLX icon
27
Amylyx Pharmaceuticals
AMLX
$2.31B
$513K 0.48%
+269,803
New +$523K
B
28
Barrick Mining
B
$63.2B
$500K 0.47%
29,979
-1,213
-4% -$20.6K
MBIN icon
29
Merchants Bancorp
MBIN
$2.55B
$410K 0.38%
10,125
– –
DUK icon
30
Duke Energy
DUK
$98.4B
$361K 0.34%
3,600
– –
OXY.WS icon
31
Occidental Petroleum Corp Warrants
OXY.WS
$32B
$343K 0.32%
8,339
-166
-2% -$7.01K
BCIM
32
DELISTED
abrdn Bloomberg Industrial Metals Strategy K-1 Free ETF
BCIM
$310K 0.29%
13,272
-489
-4% -$11.8K
F icon
33
Ford
F
$59.3B
$259K 0.24%
20,650
– –
XOM icon
34
ExxonMobil
XOM
$651B
$220K 0.2%
1,908
– –
GE icon
35
GE Aerospace
GE
$368B
$212K 0.2%
1,331
-337
-20% -$53.8K
PG icon
36
Procter & Gamble
PG
$335B
$208K 0.19%
1,260
– –
1
2

Similar funds

CIP
Castlefield Investment Partners Manchester $131M AUM
EIM
Emmett Investment Management New York $131M AUM 25.7% 1-Year Est. Return
ADEF
ABS Direct Equity Fund Stamford, Connecticut $131M AUM 7.53% 1-Year Est. Return
LC
LTG Capital Newton, Massachusetts $131M AUM 19.7% 1-Year Est. Return
EWP
Evergreen Wealth Partners Kalispell, Montana $131M AUM
SPWM
Schrum Private Wealth Management St. Augustine, Florida $131M AUM 18.38% 1-Year Est. Return
CF
Collier Financial Denver, Colorado $131M AUM
A
AFBI Miami Beach, Florida $131M AUM

Aldebaran Capital's Q2 2024 Portfolio in Review

As of Q2 2024, Aldebaran Capital held 36 positions worth $107M, up 2.3% from $105M the previous quarter. Its ten largest holdings account for 77% of the portfolio.

Aldebaran Capital's Q2 2024 filing shows 3 new, 4 increased and 21 reduced positions. Its largest new stake was Aclaris Therapeutics: 858,152 shares worth $944K. The largest sale was Bunge Global, an estimated $244K.

By sector, the portfolio is most concentrated in Financials at 26% of assets, down from 27% a quarter earlier, followed by Energy and Technology.

  • Aldebaran Capital's largest Q2 2024 buy was Aclaris Therapeutics: 858,152 shares worth $944K.
  • Aldebaran Capital added most to Cato Corp in Q2 2024, an estimated $91.3K increase.
  • Aldebaran Capital's biggest Q2 2024 reduction was Bunge Global, cutting an estimated $244K.
  • Aldebaran Capital's ten largest holdings make up 77% of its $107M portfolio in Q2 2024.
  • Aldebaran Capital opened 3 new positions and closed 0 in Q2 2024.
  • Aldebaran Capital's portfolio value rose 2.3% quarter-over-quarter to $107M.

Based on Aldebaran Capital's 13F filing for Q2 2024, filed 13 Aug 2024.